$46.69
+1.88 (+4.20%)
Open$44.88
Previous Close$44.81
Day High$46.74
Day Low$44.57
52W High$49.76
52W Low$11.26
Volume—
Avg Volume1.38M
Market Cap2.32B
P/E Ratio20.88
EPS$2.07
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+6.7% upside
Current
$46.69
$46.69
Target
$49.81
$49.81
$29.15
$49.81 avg
$64.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 362.35M | 342.87M | 329.37M |
| Net Income | -20,370,768 | -17,348,307 | -60,795,749 |
| Profit Margin | -5.6% | -5.3% | -18.5% |
| EBITDA | -26,883,110 | -24,166,308 | -79,903,104 |
| Free Cash Flow | — | — | -60,969,564 |
| Rev Growth | +5.7% | +5.7% | -9.3% |
| Debt/Equity | — | — | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |